ArticleTrials2025

Two-fraction Ultrahypofractionated Radiotherapy with focal BOost for intermediate-risk, localized prostate cancer (TURBO): study protocol of a phase II, randomized controlled clinical trial.

T A Lalmahomed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.